riboflavin ophthalmic solution
Phase 3Completed 0 watching 0 views this week๐ Rising
74
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 24
Phase 35
ApprovedIndication / Disease
Progressive Keratoconus
Conditions
Progressive Keratoconus
Trial Timeline
Dec 1, 2007 โ Apr 1, 2011
NCT ID
NCT00647699About riboflavin ophthalmic solution
riboflavin ophthalmic solution is a phase 3 stage product being developed by Glaukos for Progressive Keratoconus. The current trial status is completed. This product is registered under clinical trial identifier NCT00647699. Target conditions include Progressive Keratoconus.
Hype Score Breakdown
Clinical
27
Activity
18
Company
7
Novelty
9
Community
10
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00674661 | Phase 3 | Completed |
| NCT00647699 | Phase 3 | Completed |
Competing Products
20 competing products in Progressive Keratoconus